Di Tacchio, Mariangela <br/><br/>
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF.  [electronic resource] 

 -  Cancer immunology research  Dec 2019 
 - 1910-1927 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2326-6074 
<br/><br/><label>Standard No.: </label>10.1158/2326-6066.CIR-18-0865  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Angiopoietin-2--antagonists & inhibitors<br/>Animals<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Brain--blood supply<br/>Brain Neoplasms--blood supply<br/>Cell Line, Tumor<br/>Female<br/>Glioblastoma--blood supply<br/>Humans<br/>Immune Tolerance--drug effects<br/>Mice, Inbred C57BL<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors